BRAZILIAN PHARMACEUTICAL COMPANY REQUESTS REGULATORY APPROVAL FOR EMERGENCY USE OF RUSSIAN COVID-19 VACCINE SPUTNIK V - STATEMENT
16 Jan 2021 / 09:19 H.
BRAZILIAN PHARMACEUTICAL COMPANY REQUESTS REGULATORY APPROVAL FOR EMERGENCY USE OF RUSSIAN COVID-19 VACCINE SPUTNIK V - STATEMENT
Did you like this article?
